Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

Sabina Sangaletti, Claudia Chiodoni, Claudio Tripodo, Mario P. Colombo

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The complex interaction between cells undergoing transformation and the various stromal and immunological cell components of the tumor microenvironment (TME) crucially influences cancer progression and diversification, as well as endowing clinical and prognostic significance. The immunosuppression characterizing the TME depends on the recruitment and activation of different cell types including regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Less considered is the non-cellular component of the TME. Here, we focus on the extracellular matrix (ECM) regulatory activities that, within the TME, actively contribute to many aspects of tumor progression, acting on both tumor and immune cells. Particularly, ECM-mediated regulation of tumor-associated immunosuppression occurs through the modulation of myeloid cell expansion, localization, and functional activities. Such regulation is not limited to the TME but occurs also within the bone marrow, wherein matricellular proteins contribute to the maintenance of specialized hematopoietic stem cell niches thereby regulating their homeostasis as well as the generation and expansion of myeloid cells under both physiological and pathological conditions. Highlighting the commonalities among ECM-myeloid cell interactions in bone marrow and TME, in this review we present a picture in which myeloid cells might sense and respond to ECM modifications, providing different ECM-myeloid cell interfaces that may be useful to define prognostic groups and to tailor therapeutic interventions.

Original languageEnglish
Pages (from-to)1059-1067
Number of pages9
JournalCancer Immunology, Immunotherapy
Volume66
Issue number8
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Tumor Microenvironment
Myeloid Cells
Extracellular Matrix
Bone Marrow
Neoplasms
Cell Communication
Immunosuppression
Stem Cell Niche
Regulatory T-Lymphocytes
Cellular Structures
Stromal Cells
Hematopoietic Stem Cells
Homeostasis
Macrophages
Maintenance
Proteins

Keywords

  • Bone marrow niche
  • Extracellular matrix
  • Regulatory myeloid suppressor cells
  • SPARC
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments. / Sangaletti, Sabina; Chiodoni, Claudia; Tripodo, Claudio; Colombo, Mario P.

In: Cancer Immunology, Immunotherapy, Vol. 66, No. 8, 01.08.2017, p. 1059-1067.

Research output: Contribution to journalReview article

@article{2f6b391dfed74a44a004b1f6342257d5,
title = "Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments",
abstract = "The complex interaction between cells undergoing transformation and the various stromal and immunological cell components of the tumor microenvironment (TME) crucially influences cancer progression and diversification, as well as endowing clinical and prognostic significance. The immunosuppression characterizing the TME depends on the recruitment and activation of different cell types including regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Less considered is the non-cellular component of the TME. Here, we focus on the extracellular matrix (ECM) regulatory activities that, within the TME, actively contribute to many aspects of tumor progression, acting on both tumor and immune cells. Particularly, ECM-mediated regulation of tumor-associated immunosuppression occurs through the modulation of myeloid cell expansion, localization, and functional activities. Such regulation is not limited to the TME but occurs also within the bone marrow, wherein matricellular proteins contribute to the maintenance of specialized hematopoietic stem cell niches thereby regulating their homeostasis as well as the generation and expansion of myeloid cells under both physiological and pathological conditions. Highlighting the commonalities among ECM-myeloid cell interactions in bone marrow and TME, in this review we present a picture in which myeloid cells might sense and respond to ECM modifications, providing different ECM-myeloid cell interfaces that may be useful to define prognostic groups and to tailor therapeutic interventions.",
keywords = "Bone marrow niche, Extracellular matrix, Regulatory myeloid suppressor cells, SPARC, Tumor microenvironment",
author = "Sabina Sangaletti and Claudia Chiodoni and Claudio Tripodo and Colombo, {Mario P.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s00262-017-2014-y",
language = "English",
volume = "66",
pages = "1059--1067",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "8",

}

TY - JOUR

T1 - Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

AU - Sangaletti, Sabina

AU - Chiodoni, Claudia

AU - Tripodo, Claudio

AU - Colombo, Mario P.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The complex interaction between cells undergoing transformation and the various stromal and immunological cell components of the tumor microenvironment (TME) crucially influences cancer progression and diversification, as well as endowing clinical and prognostic significance. The immunosuppression characterizing the TME depends on the recruitment and activation of different cell types including regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Less considered is the non-cellular component of the TME. Here, we focus on the extracellular matrix (ECM) regulatory activities that, within the TME, actively contribute to many aspects of tumor progression, acting on both tumor and immune cells. Particularly, ECM-mediated regulation of tumor-associated immunosuppression occurs through the modulation of myeloid cell expansion, localization, and functional activities. Such regulation is not limited to the TME but occurs also within the bone marrow, wherein matricellular proteins contribute to the maintenance of specialized hematopoietic stem cell niches thereby regulating their homeostasis as well as the generation and expansion of myeloid cells under both physiological and pathological conditions. Highlighting the commonalities among ECM-myeloid cell interactions in bone marrow and TME, in this review we present a picture in which myeloid cells might sense and respond to ECM modifications, providing different ECM-myeloid cell interfaces that may be useful to define prognostic groups and to tailor therapeutic interventions.

AB - The complex interaction between cells undergoing transformation and the various stromal and immunological cell components of the tumor microenvironment (TME) crucially influences cancer progression and diversification, as well as endowing clinical and prognostic significance. The immunosuppression characterizing the TME depends on the recruitment and activation of different cell types including regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Less considered is the non-cellular component of the TME. Here, we focus on the extracellular matrix (ECM) regulatory activities that, within the TME, actively contribute to many aspects of tumor progression, acting on both tumor and immune cells. Particularly, ECM-mediated regulation of tumor-associated immunosuppression occurs through the modulation of myeloid cell expansion, localization, and functional activities. Such regulation is not limited to the TME but occurs also within the bone marrow, wherein matricellular proteins contribute to the maintenance of specialized hematopoietic stem cell niches thereby regulating their homeostasis as well as the generation and expansion of myeloid cells under both physiological and pathological conditions. Highlighting the commonalities among ECM-myeloid cell interactions in bone marrow and TME, in this review we present a picture in which myeloid cells might sense and respond to ECM modifications, providing different ECM-myeloid cell interfaces that may be useful to define prognostic groups and to tailor therapeutic interventions.

KW - Bone marrow niche

KW - Extracellular matrix

KW - Regulatory myeloid suppressor cells

KW - SPARC

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85019195194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019195194&partnerID=8YFLogxK

U2 - 10.1007/s00262-017-2014-y

DO - 10.1007/s00262-017-2014-y

M3 - Review article

C2 - 28501940

AN - SCOPUS:85019195194

VL - 66

SP - 1059

EP - 1067

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 8

ER -